BERLIN, July 2, 2008 (PRIME NEWSWIRE) -- aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment and active in medical biomaterials, fracture healing and joint replacement, achieved in the first six months of the financial year 2008 -- according to preliminary figures -- a sales growth of 29% to EUR 16.4 million (first half of 2007: EUR 12.7 million).
